U.S. patent number 10,405,747 [Application Number 15/878,034] was granted by the patent office on 2019-09-10 for analyte meter including an rfid reader.
This patent grant is currently assigned to Abbott Diabetes Care, Inc.. The grantee listed for this patent is Abbott Diabetes Care Inc.. Invention is credited to Timothy T. Goodnow, Lei (Lawrence) He.
![](/patent/grant/10405747/US10405747-20190910-D00000.png)
![](/patent/grant/10405747/US10405747-20190910-D00001.png)
![](/patent/grant/10405747/US10405747-20190910-D00002.png)
![](/patent/grant/10405747/US10405747-20190910-D00003.png)
![](/patent/grant/10405747/US10405747-20190910-D00004.png)
![](/patent/grant/10405747/US10405747-20190910-D00005.png)
![](/patent/grant/10405747/US10405747-20190910-D00006.png)
![](/patent/grant/10405747/US10405747-20190910-D00007.png)
![](/patent/grant/10405747/US10405747-20190910-D00008.png)
![](/patent/grant/10405747/US10405747-20190910-D00009.png)
![](/patent/grant/10405747/US10405747-20190910-D00010.png)
View All Diagrams
United States Patent |
10,405,747 |
Goodnow , et al. |
September 10, 2019 |
Analyte meter including an RFID reader
Abstract
A glucose monitoring system, includes a glucose sensor strip or
package of strips. The strip includes a substrate and a glucose
monitoring circuit that has electrodes and a bodily fluid
application portion of selected chemical composition. An antenna is
integrated with the glucose sensor strip. A RFID sensor chip is
coupled with the glucose sensor strip and the antenna. The chip has
a memory containing digitally-encoded data representing calibration
and/or expiration date information for the strip.
Inventors: |
Goodnow; Timothy T.
(Pleasanton, CA), He; Lei (Lawrence) (Moraga, CA) |
Applicant: |
Name |
City |
State |
Country |
Type |
Abbott Diabetes Care Inc. |
Alameda |
CA |
US |
|
|
Assignee: |
Abbott Diabetes Care, Inc.
(Alameda, CA)
|
Family
ID: |
36793657 |
Appl.
No.: |
15/878,034 |
Filed: |
January 23, 2018 |
Prior Publication Data
|
|
|
|
Document
Identifier |
Publication Date |
|
US 20180160906 A1 |
Jun 14, 2018 |
|
Related U.S. Patent Documents
|
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
Issue Date |
|
|
15136310 |
Apr 22, 2016 |
9907470 |
|
|
|
14746370 |
May 10, 2016 |
9336423 |
|
|
|
14313619 |
Jun 23, 2015 |
9060805 |
|
|
|
13852276 |
Jun 24, 2014 |
8760297 |
|
|
|
13342715 |
Apr 2, 2013 |
8410939 |
|
|
|
12476921 |
Jan 31, 2012 |
8106780 |
|
|
|
11350398 |
Jun 9, 2009 |
7545272 |
|
|
|
60650912 |
Feb 8, 2005 |
|
|
|
|
60701654 |
Jul 21, 2005 |
|
|
|
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
A61B
5/1486 (20130101); A61B 5/14503 (20130101); G01N
33/48771 (20130101); G06K 7/10366 (20130101); G08C
17/02 (20130101); A61B 5/0026 (20130101); A61B
5/7275 (20130101); A61B 5/14532 (20130101); A61B
5/0022 (20130101); A61B 5/150358 (20130101); A61B
5/742 (20130101); A61B 5/0004 (20130101); A61B
90/98 (20160201); A61B 90/90 (20160201); A61B
5/7282 (20130101); A61B 5/1473 (20130101); A61B
5/14735 (20130101); A61B 5/1495 (20130101); A61B
2562/08 (20130101); A61B 2562/0295 (20130101); A61B
2562/085 (20130101) |
Current International
Class: |
H04Q
5/22 (20060101); A61B 5/145 (20060101); A61B
5/1486 (20060101); A61B 90/90 (20160101); A61B
5/00 (20060101); G01N 33/487 (20060101); A61B
5/1495 (20060101); A61B 90/98 (20160101); G06K
7/10 (20060101); A61B 5/15 (20060101); A61B
5/1473 (20060101); G08C 17/02 (20060101) |
Field of
Search: |
;340/572.1,572.8,573.1,10.1 ;600/347 |
References Cited
[Referenced By]
U.S. Patent Documents
Primary Examiner: La; Anh V
Attorney, Agent or Firm: Vorys, Sater, Seymour and Pease
LLP
Parent Case Text
PRIORITY
This application is a continuation of U.S. patent application Ser.
No. 15/136,310, filed Apr. 22, 2016 is a continuation of U.S.
patent application Ser. No. 14/746,370, filed Jun. 22, 2015, now
U.S. Pat. No. 9,336,423, which is a continuation of U.S. patent
application Ser. No. 14/313,619, filed Jun. 24, 2014, now U.S. Pat.
No. 9,060,805, which is a continuation of U.S. patent application
Ser. No. 13/852,276, filed Mar. 28, 2013, now U.S. Pat. No.
8,760,297, which is a continuation of U.S. patent application Ser.
No. 13/342,715, filed Jan. 3, 2012, now U.S. Pat. No. 8,410,939,
which is a continuation of U.S. patent application Ser. No.
12/476,921, filed Jun. 2, 2009, now U.S. Pat. No. 8,106,780, which
is a continuation of U.S. patent application Ser. No. 11/350,398,
filed Feb. 7, 2006, now U.S. Pat. No. 7,545,272, which claims the
benefit of priority to U.S. provisional patent applications Nos.
60/650,912, filed Feb. 8, 2005 and 60/701,654, filed Jul. 21, 2005,
which are incorporated by reference.
Claims
What is claimed is the following:
1. An analyte measurement system comprising: an in vivo implanted
or partially implanted analyte sensor comprising an RFID sensor
chip, the RFID sensor chip comprising memory having digitally
encoded information including a manufacturer calibration code; and
an analyte meter comprising: circuitry configured to receive one or
more signals indicative of an analyte level; a display; and an RFID
reader configured to receive the digitally encoded information and
the one or more signals indicative of the analyte level.
2. The analyte measurement system of claim 1, wherein the digitally
encoded information further comprises data selected from the group
consisting of expiration information, data representing a lot
number, data representing a manufacture date, data representing a
sensor type, and any combination thereof.
3. The analyte measurement system of claim 1, wherein the circuitry
is configured to determine the analyte level based on the one or
more signals indicative of the analyte level.
4. The analyte measurement system of claim 1, wherein the display
is configured to display graphical and textual representations
based on the analyte level.
5. The analyte measurement system of claim 1, wherein the analyte
meter is configured to alert a user of a warning based on the
analyte level.
6. The analyte measurement system of claim 1, wherein the analyte
sensor is a glucose sensor.
7. The analyte measurement system of claim 1, wherein the analyte
sensor is a continuous glucose monitoring system.
8. The analyte measurement system of claim 1, wherein the RFID
reader is in communication with an insulin pump.
9. The analyte measurement system of claim 1, wherein the RFID
reader comprises a transceiver and an antenna.
10. The analyte measurement system of claim 1, wherein the analyte
sensor further comprises an antenna.
11. A method for determining an analyte level comprising:
interrogating an in vivo implanted or partially implanted analyte
sensor comprising an RFID sensor chip with an analyte meter, the
RFID sensor chip comprising memory having digitally encoded
information including a manufacturer calibration code, and the
analyte meter comprising: circuitry configured to receive one or
more signals indicative of an analyte level; a display; and an RFID
reader configured to receive the digitally encoded information and
the one or more signals indicative of the analyte level; and
receiving via the circuitry the one or more signals indicative of
the analyte level; and determining via the circuitry the analyte
level based on the one or more signals indicative of the analyte
level.
12. The method of claim 11, further comprising displaying graphical
and textual representations based on the analyte level.
13. The method of claim 11, further comprising alerting a user of a
warning based on the analyte level via the analyte meter.
14. The method of claim 13, wherein the alert is selected from the
group consisting of audible, sensory, visual, and any combination
thereof.
15. The method of claim 11, wherein the digitally encoded
information further comprises data selected from the group
consisting of expiration information, data representing a lot
number, data representing a manufacture date, data representing a
sensor type, and any combination thereof.
16. The analyte measurement system of claim 11, wherein the analyte
sensor is a glucose sensor.
17. The analyte measurement system of claim 11, wherein the analyte
sensor is a continuous glucose monitoring system.
18. The analyte measurement system of claim 11, wherein the RFID
reader is in communication with an insulin pump.
19. The analyte measurement system of claim 11, wherein the RFID
reader comprises a transceiver and an antenna.
20. The analyte measurement system of claim 11, wherein the analyte
sensor further comprises an antenna.
Description
BACKGROUND
Diabetes care involves periodically checking the blood glucose
level of a bodily fluid such as blood. Based on the measured bodily
fluid level, a diabetic may take one or more steps such as
injecting insulin or consuming carbohydrates to bring the level
back to a desired level.
Glucose Meters
FIG. 1 illustrates a conventional blood glucose meter 100 (see U.S.
Design Pat. No. D393,313, which is hereby incorporated by
reference). The meter 100 includes a test strip slot 102, a display
104 and one or more operational buttons 106. Although not shown in
FIG. 1, the meter 100 also includes component circuitry for
receiving signals that depend on the glucose level of a fluid
applied to a strip that is inserted into the slot 102, and
component circuitry for determining the glucose level based on the
received signals. FIG. 2 illustrates a blood glucose meter 200 with
display 104 and operational buttons 106, and also having a glucose
test strip 202 inserted into a slot 102 for testing a body fluid
sample applied to the strip 202.
GLUCOSE SENSORS
Small volume (e.g., less than 0.5 microliter), in vitro,
electrochemical sensors are used with Freestyle.RTM. and Freestyle
Flash.TM. glucose meters (see the website located by placing
http://ADCI-164CON directly preceding abbottdiabetescare.com, which
is hereby incorporated by reference). These test strip sensors
generally include a working electrode on a first substrate, a
counter (or counter/reference) electrode on a second substrate, and
a sample chamber. The sample chamber is configured so that when a
sample (e.g., of blood) is provided in the chamber, the sample is
in electrolytic contact with both the working electrode, the
counter electrode and any reference electrodes or indicator
electrodes that may be present. This allows electrical current to
flow between the electrodes to effect the electrolysis
(electrooxidation or electroreduction) of the analyte. A spacer is
generally positioned between first substrate and second substrate
to provide a spacing between electrodes and to provide the sample
chamber in which the sample to be evaluated is housed.
FIGS. 3A-3C illustrates one of these test strips (see U.S. Pat. No.
6,942,518, which is assigned to the same assignee as the present
application, and is hereby incorporated by reference). This
configuration is used for side-filling, and end-filling is an
alternative. FIG. 3A illustrates a first substrate 340 with a
working electrode 342. FIG. 3B illustrates a spacer 344 defining a
channel 346. FIG. 3C (inverted with respect to FIGS. 3A and 3B)
illustrates a second substrate 348 with three counter (or
counter/reference) electrodes 350, 352, 354. This multiple counter
electrode arrangement can provide a fill indicator function, as
described below. The length of the channel 346 is typically defined
by the two parallel cuts along the sides 356, 358 of the
sensors.
Glucose test strip sensors can be manufactured adjacent to one
another, as illustrated in FIGS. 4A-4B. Such positioning during
manufacture produces less waste material. This often results in
better efficiency as compared to other techniques, such as
individually placing components within the individual channels of
test strip sensors.
General Method for Manufacturing Glucose Sensors
FIGS. 4A-4B illustrate the processing of a sheet 1000 of test
strips. Referring now to FIGS. 4A and 4B, one example of a method
for making thin film sensors is generally described, and can be
used to make a variety of sensor arrangements. When the three
layers of the test strips of FIGS. 3A-3C, e.g., are assembled, a
sensor is formed.
In FIGS. 4A and 4B, a substrate 400, such as a plastic substrate,
is moving in the direction indicated by the arrow. The substrate
400 can be an individual sheet or a continuous roll on a web.
Multiple sensors can be formed on a substrate 400 as sections 422
that have working electrodes thereon and sections 424 that have
counter electrodes and indicator electrodes thereon. These working,
counter and indicator electrodes are electrically connected to
corresponding traces and contact pads. Typically, working electrode
sections 422 are produced on one half of substrate 400 and counter
electrode sections 424 are produced on the other half of substrate
400. In some embodiments, the substrate 400 can be scored and
folded to bring the sections 422, 424 together to form the sensor.
In some embodiments, as illustrated in FIG. 4A, the individual
working electrode sections 422 can be formed next to or adjacent
each other on the substrate 400, to reduce waste material.
Similarly, individual counter electrode sections 424 can be formed
next to or adjacent each other. In other embodiments, the
individual working electrode sections 422 (and, similarly, the
counter electrode sections 424) can be spaced apart, as illustrated
in FIG. 4B.
Radio Frequency Identification (RFID)
RFID provides an advantageous technology for remotely storing and
retrieving data using devices called RFID tags. A RFID tag is a
small object, such as an adhesive sticker, that can be attached to
or incorporated into a product. There are passive and active RFID
tags. Passive RFID tags are small devices that are generally used
at shorter range and for simpler tracking and monitoring
applications than active tags. Passive tags generally act over
ranges up to 3-5 meters, and a few hundred are typically readable
simultaneously within three meters of a reader. Because they are
powered by radio waves from RFID tag reader, passive tags do not
use a battery. Therefore these devices are generally inexpensive
and smaller than active tags, and can last long. Active RFID tags
have a power source, such as a battery, and generally have longer
range and larger memories than passive tags. For example, active
tags generally act over ranges up to 100 meters, and thousands of
tags are typically readable simultaneously within 100 meters of a
reader. For more details on passive and active RFID tags, see the
website located by placing http:// directly preceding
RFID-Handbook.com, which is hereby incorporated by reference.
RFID System
An RFID system generally includes a RFID tag and RFID reader. A
RFID tag includes an antenna and digital memory chip. A RFID
reader, also called an interrogator, includes an antenna and a
transceiver, and emits and receives RF signals. RFID readers can
read tags and can typically write data into the tags. For example,
FIG. 5 schematically illustrates component circuitry of a passive
RFID tag. A transceiver/receiver 502 of a RFID reader 505 is
directionally coupled 504 to an antenna 506 of the reader 505. An
RFID transponder 510 includes an antenna 512 (e.g., a dipole
antenna) and memory 514. It is desired to incorporate RFID tag
technology into glucose test strips, test strip vials and/or boxes
of strips. It is also desired to incorporate RFID reader into
glucose meters.
SUMMARY OF THE INVENTION
A glucose monitoring system includes a glucose sensor strip or
package of strips. The strip includes a substrate and a glucose
monitoring circuit that has electrodes and a bodily fluid
application portion of selected chemical composition. An antenna is
integrated with the glucose sensor strip. A RFID sensor chip is
coupled with the glucose sensor strip and the antenna. The chip has
a memory containing digitally-encoded data representing calibration
and/or expiration date information for the strip.
The antenna may be a loop antenna that has a conducting loop
extending around substantially a perimeter of the substrate and has
two ends coupled with the chip. A RFID reader may read, power
and/or program the chip. The RFID reader may be integrated with a
glucose meter that has a port for inserting the strip and measuring
a glucose level. Alternatively, a glucose meter may include a RFID
reader as a component. The calibration and/or expiration date data
may be automatically read when the strip is inserted into the port
of the glucose meter. The chip may include a battery or other power
source, or may be a passive chip. The memory may also contain data
representing a lot number of the strip, manufacture date for the
strip, a type of strip, and/or a calibration code. The RFID sensor
chip may operate at 13.56 MHz. The calibration data may include
chemical composition information for the strip for accurately
computing a glucose level based on the chemical composition.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 illustrates a conventional blood glucose meter.
FIG. 2 illustrates a blood glucose meter having a strip inserted
into a slot for testing a body fluid sample applied to the
strip.
FIGS. 3A-3C illustrate a conventional test strip.
FIGS. 4A-4B illustrate the processing of a sheet of test
strips.
FIG. 5 illustrates a conventional passive RFID tag.
FIG. 6 illustrates a glucose test strip including a RFID chip and
antenna in accordance with a preferred embodiment.
FIG. 7 is an exploded view of a glucose test strip in accordance
with a preferred embodiment.
FIG. 8 illustrates a RFID chip mounted on a glucose test strip in
accordance with a preferred embodiment.
FIG. 9 illustrates a communication system including a glucose test
strip and a RFID reader in accordance with a preferred
embodiment.
FIG. 10 illustrates a RFID chip mounted on a package for holding
glucose test strips in accordance with a preferred embodiment.
FIG. 11 illustrates a glucose meter communicating with a RFID tag
that is mounted ona package or box of glucose test strips in
accordance with a preferred embodiment.
FIG. 12 illustrates a glucose meter communicating with a RFID tag
that is mounted on a glucose test strip in accordance with a
preferred embodiment.
FIG. 13 illustrates a line graph of blood glucose data generated by
an integrated glucose monitoring apparatus according to a preferred
embodiment.
FIG. 14 illustrates pie charts of blood glucose data generated by
an integrated glucose monitoring apparatus and displayed on a
display screen 166 according to a preferred embodiment.
FIG. 15 illustrates a glucose data handling system software
according to a preferred embodiment in block diagram form. A
measurement module (90), glucose strip (92), personal digital
assistant (PDA) (Palm OS) (94), (PC) (Windows 95+), monitor (98),
keyboard (101), compact disk (CD) (102), and printer (104) are
shown in block diagram form.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
A RFID sensor is advantageously coupled with a blood glucose test
strip or with a group of strips in accordance with a preferred
embodiment. The RFID sensor preferably includes calibration and/or
expiration date information for the strips. The calibration
information preferably includes information relating to the
chemical composition of the strip, so that a blood glucose reading
can be accurately computed from a reading obtained using the strip
with the particular chemical composition.
In one embodiment, an individual strip includes a RFID sensor. FIG.
6 illustrates a glucose test strip 600, e.g., a Freestyle.RTM. test
strip manufactured by Abbott Diabetes Care of Alameda, Calif., that
includes a RFID chip 602, which is mounted on a PCB substrate 603
or other suitable substrate, and an antenna 604, in accordance with
a preferred embodiment. The antenna 604 may be a loop antenna, or a
dipole antenna, or another antenna configuration.
FIG. 7 is an exploded view of a Freestyle.RTM. or other glucose
test strip 600 including a sample application end 601, with sample
chamber and electrodes, a RFID chip 602 in accordance with a
preferred embodiment. The RFID chip 602 is mounted on a PCB
substrate 603 that is attached to, integral with or part of the
strip 600. There is a top-side loop antenna 708 and a bottom side
loop antenna 710. FIG. 8 illustrates a RFID chip 602 mounted on a
glucose test strip 600 in accordance with another embodiment.
Preferably a RFID reader programs the RFID sensor with the
calibration data and/or powers the RFID sensor. The RFID reader may
be integrated with a blood glucose meter, or the meter may include
an RFID reader as a component. FIG. 9 illustrates a communication
system including a RFID reader 902 and a tag 904 in accordance with
a preferred embodiment. The reader 902 includes a reader antenna
903. The tag 904 may be coupled with a glucose test strip or with a
package or box of strips. The tag 904 includes a substrate 906, tag
antenna 908 and RFID chip 910. The reader 902 sends a radio wave
that impinges upon the tag 904. A backscattering radio wave is
propagated back from the tag 904 as a result.
FIG. 10 illustrates a RFID chip mounted on a package for holding
glucose test strips in accordance with a preferred embodiment. The
package illustrated is a lid of a vial container of several tens of
test strips. Preferably, each of the test strips in the vial was
manufactured on a same sheet of strips, such that the chemical
compositions of the strips are very similar and that the strips
have a common expiration date.
Meters Equipped with a RFID Tag Reader (or vice-versa)
In accordance with another advantageous embodiment, a RFID tag
reader or interrogator may be adapted for providing glucose
testing. As such, a test strip receptacle and glucose measurement
circuitry and/or programming may be provided in a glucose meter
module that plugs into a RFID reader device or is integrated
therein or otherwise communicates data and/or power by cable or
multi-pin connection, or wirelessly (at least for the data
communication) with the RFID reader. The glucose meter module can
use the power and processing capabilities of the reader, thus
streamlining the meter module compared with a stand-alone meter.
Even data storage for both the reader and meter may be combined
into one location or otherwise synchronized.
In another embodiment, a glucose meter may be adapted for providing
RFID reading and/or writing. A RFID reader may be provided that
plugs into a glucose meter or is integrated therein or otherwise
communicates data and/or power by cable, or multi-pin connection,
or wirelessly (at least for the data communication) with the
glucose meter. The RFID reader can use the power and processing
capabilities of the meter, thus streamlining the RFID reader module
compared with a stand-alone reader. Even data storage for both the
reader and meter may be combined into one location or otherwise
synchronized.
Human errors are advantageously prevented by automatically
retrieving a calibration code of one or more test strips stored in
a RFID tag. Expiration date information for the test strip can also
be detected from the tag. Different types of test strips can also
be detected, which is advantageous particularly for different
strips that appear alike and/or that may be used with a same piece
of diabetes care equipment. Several other possible types of data
may be stored in and read from a RFID tag, which may be used alone
and/or may be combined with other diabetes care data to enhance the
reliability of a diabetes treatment regimen, including the
recording, retrieval and/or use of relevant data (see, e.g., U.S.
patent application Ser. No. 10/112,671 (U.S. Publication No.
2003/0176183) and Ser. No. 11/146,897 (U.S. Publication No.
2006/0010098), which are assigned to the same assignee and are
hereby incorporated by reference). Embodiments disclosed in the
Ser. No. 10/112,671 (U.S. Publication No. 2003/0176183)
application, and in U.S. Pat. Nos. 5,899,855, 5,735,285, 5,961,451,
6,159,147 and 5,601,435, which are hereby incorporated by
reference, describe alternative arrangements for combining
functionalities of devices that may be modified for use with an
advantage glucose meter and RFID reader combination in accordance
with a preferred embodiment.
U.S. Pat. No. 5,899,855 indicates, for example, that relatively
easy-to-use blood glucose monitoring systems have become available
that provide reliable information that allows a diabetic and his or
her healthcare professional to establish, monitor and adjust a
treatment plan (diet, exercise, and medication). More specifically,
microprocessor-based blood glucose monitoring systems are being
marketed which sense the glucose level of a blood sample that is
applied to a reagent-impregnated region of a test strip that is
inserted in the glucose monitor. When the monitoring sequence is
complete, the blood glucose level is displayed by, for example, a
liquid crystal display (LCD) unit.
Additional display functionalities are described in U.S.
Publication No. 2003/0176183, which relates to a blood glucose
monitor and data management and display device integrated as a
synchronous, handheld unit, as an effective diabetes management
tool. U.S. Publication No. 2003/0176183 indicates, for example,
that a display component of an integrated glucose monitoring
apparatus may be a touchscreen and may be configured to function
with touchscreen software and electronics.
U.S. Publication No. 2003/0176183 also describes a data management
application. The data management application generally provides
graphic representations and/or text summaries of data relevant to
diabetes management.
U.S. Publication No. 2003/0176183 indicates that the data
management application may be configured to allow the user to view
data summaries in graphical and text formats. The user may be able
to select the length of time to be viewed. The user may also be
able to set a default length of time to be viewed from within user
preferences. The user may be able to view a complete data set or
filter the screen display to show only a selected time period to
view. The user may be able to select the event type to be
displayed, more than one event type may be selected to be displayed
simultaneously. Glucose summary statistics may be displayed by a
selected date range and time period. Both selected date range and
time period may appear on the display. The summary statistics may
include the number of measurements, the highest measurement, the
lowest measurement, the average measurement, the standard deviation
of the measurements, the percentage of measurements within the
target range, the percentage of measurements above the target
range, the percentage of measurements below the target range, and
insulin and carbohydrate statistics summary. Graphical summaries
may also be provided such as line graphs and pie charts (see FIGS.
13-14).
U.S. Publication No. 2003/0176183 indicates that the data
management application may be configured to issue "alerts". These
alerts may be warnings directed to the user that are audible, or
otherwise sensory such as by vibration, and displayed with graphics
and/or text using the display screen.
The integrated glucose monitoring apparatus described in U.S.
Publication No. 2003/0176183 may generate, for example, a line
graph of blood glucose data generated by an integrated glucose
monitoring apparatus according to a preferred embodiment. The line
graph of FIG. 13 shows glucose levels according to the date that
the glucose level was taken. As shown, a glucose level that was
recorded on November 5 at around 500 mg/dL is labeled as being "Hi"
while a glucose level recorded on October 21 at around 20 mg/dL is
labeled as "Lo". A range between around 80 mg/dL and 140 mg/dL is
indicated by dashed lines in FIG. 13 suggesting an optimal glucose
level range.
FIG. 14 illustrates pie charts of blood glucose data generated by
an integrated glucose monitoring apparatus according to a preferred
embodiment. The graphs show the percentage of readings that are
below, within or above target. For example, chart (a) shows that
overall 39% of the time the readings are within target or within
the optimal glucose level range of FIG. 13. Charts (b)-(g) show the
percentages of readings that are below, within or above target
pre-breakfast, pre-lunch, pre-dinner, post-breakfast, post-lunch
and post-dinner, respectively. The user can understand his or her
glucose level trends from these graphs.
U.S. Publication No. 2003/0176183 indicates that the integrated
glucose monitoring apparatus described therein may be configured to
HotSync with a PC for transmitting data to a PC. The integrated
glucose monitoring apparatus may also transmit data by wireless RF
and/or IR connection to a remote or host client or server computer.
The integrated glucose monitoring apparatus also preferably has
internet connectability or is otherwise configured for logging into
a network for transmitting and receiving data from the network.
U.S. Publication No. 2003/0176183 also indicates that applications
may be downloaded to the integrated glucose monitoring apparatus or
another device from a PC or a server or other digital data storage
device such as a CD-rom or magnetic disk.
U.S. Publication No. 2003/0176183 also indicates that the hand-held
processing device component of the integrated glucose monitoring
apparatus may be configured for serial port or USB connection to a
PC system. See, e.g., FIG. 15.
FIG. 11 illustrates a glucose meter 1100 sending radio waves 1101
for communicating with a RFID tag (not specifically shown) that is
mounted on a package such as a vial 1104 or a box 1106 of glucose
test strips in accordance with preferred embodiments. In a first
embodiment, a RFID sensor is coupled with a package or vial
container 1104 of glucose test strips. The container 1104 may have
a lid 1108 with the RFID sensor attached on its inside surface, or
embedded therein, or mounted on the outside with a protective layer
affixed over it, or alternatively on the bottom of the container
1104 or otherwise. In another embodiment, the strips are contained
within a box 1102 having a RFID tag mounted preferably on the
inside of the box to protect the tag, or alternatively on the
outside having a protective layer over it.
Containers 1102 or 1104 preferably include only strips from a same
sheet of strips having same or similar chemical compositions and
expiration dates. One strip may be tested from the sheet, while the
remaining strips are placed into the container. The rest of the
strips that are placed in the container and not tested will
reliably have the same or very similar chemical composition as the
tested strip. The RFID sensor may be read only, or may also be
write programmable. The data contained within the memory of the
RFID sensor preferably includes calibration data regarding the
chemical compositions of the strips in the container 1102, 1104
which are each estimated to have the same chemical composition as
the test strip, and expiration date data for the strips, which
should be the same for all of the strips that were manufactured on
the same sheet at the same time. In accordance with another
embodiment, FIG. 12 illustrates a glucose meter 1200 communicating
with a RFID tag using radio waves 1201 that is mounted on a glucose
test strip 1202 in accordance with a preferred embodiment.
RFID Frequency Band Allocation
Multiple frequency bands are available for RFID communication in
accordance with preferred embodiments. For example, there is a low
frequency band around 125 kHz-134 kHz. There is a worldwide
standard high frequency band around 13.56 MHz. There are also UHF
frequency bands around 868 MHz for European Union countries, and
around 902 MHz-928 MHz for the United States. There is also a
microwave frequency band around 2.45 GHz.
It is preferred to use the worldwide standard around 13.56 MHz as
the frequency band of operation in accordance with a preferred
embodiment. This is the most popular frequency band, and a
silicon-based RFID chip operating at this frequency band may be
provided at low cost. This frequency band has a high efficiency RF
energy transition, and complies with a world-wide RF standard.
Test Strip Coding and Meter Calibrating
Test strip coding and meter calibrating are the processes by which
a blood glucose meter is matched with the reactivity of the test
strips. A glucose meter will calculate a glucose level of a fluid
applied to a strip based on a predetermined chemical composition of
the strip. If the predetermined composition varies from the actual
composition, then glucose test results provided by the meter will
also vary from actual glucose levels.
Even test strips intended to be manufactured with a same chemical
composition can vary based on uncertainties in the manufacturing
process. Although this variance may be only very small when great
care is taken in the manufacturing process, these very small
variances can alter glucose measurement results that are output by
a glucose meter from actual values unless the meter is properly
calibrated. As illustrated at FIGS. 4A-4B and described briefly
above, multiple test strips are advantageously manufactured
together on a same sheet. Test strips that are manufactured on a
same sheet have reduced variances in chemical composition compared
with test strip manufactured separately. Therefore, one strip from
a sheet is advantageously tested in accordance with a preferred
embodiment to determine its precise composition. Then, blood
glucose meters are calibrated according to that composition when
utilizing other strips from that same sheet for testing. As a
consequence, glucose testing results are more reliably precise and
accurate.
To ensure this precision and accuracy of glucose test results using
blood glucose meters in accordance with a preferred embodiment, the
strips may be coded, e.g., by the strip manufacturer before they
are shipped out. In addition, the glucose meter is calibrated.
Calibration of the meter can be performed by inserting a code strip
into the meter and executing a calibration routine. The
Precision.TM. meter of Abbott Diabetes Care.RTM. preferably uses
this technique. Another method of calibration can be performed by
entering a code number into the meter. This technique is preferred
for use with the Freestyle.RTM. meter also of Abbott Diabetes
Care.RTM.. Advantageously, the encoded calibration data can be
stored in the RFID chip described above that is affixed to a strip,
or a vial, box or other container of strips. Enhanced efficiency
and reliability is achieved whether an RFID chip is mounted to each
strip or to a vial, box or other container of strips. However, when
the RFID chip from which the encoded calibration data is read is
affixed to the vial, box or other container of strips, and
preferably all of the strips within that vial, box or other
container were manufactured from the same sheet of strips, as
described above, then even greater efficiency, i.e., programming
and use of a reduced number of RFID chips, is achieved.
Advantageously, one RFID chip may be used for initially programming
and for later obtaining calibration data for multiple strips.
Moreover, expiration date data may be stored and obtained in RFID
chips with the same efficiencies and advantages.
It is preferred to provide passive RFID tags on test strips, vials,
boxes and/or other containers of strips. The preferred passive RFID
tags can store approximately two kilobytes of data or more. The
memory of the passive tag can be read and written repeatedly. In
the memory, the following are preferably stored: test strip
calibration codes, lot number, manufacture date, expiration date,
other calibration information, or type of strip, or combinations
thereof.
By using RFID tags, a test strip manufacturing process is
advantageously upgraded. In this embodiment, test strips are
manufactured and preferably packed directly into final packages in
vials or boxes or other containers, instead of waiting, e.g., for
two weeks, for labeling of calibration codes. The calibration codes
are preferably written into the RFID tags after the codes are
determined. A lot group size of the test strips can be broken into
a smaller geometry to achieve a more precise uniformity of chemical
reactivity code. Further data can be stored into RFID tags, as
desired.
The calibration, expiration date and/or other diabetes care
information may be provided in a RFID chip or module associated
with glucose sensors other than test strips and test strip
containers. For example, continuous glucose sensors that may be
implanted or partially in vivo or otherwise can include RFID
features described otherwise herein. In addition, diabetes care
devices other than glucose sensors such as insulin pumps can use
the RFID communication of data such as pump calibration data,
insulin infusion data, computed or received dose data or glucose
data available at the pump. As to the latter feature, glucose data
may be communicated to a pump by a glucose meter, and then read by
a RFID reader.
The present invention is not limited to the embodiments described
above herein, which may be amended or modified without departing
from the scope of the present invention as set forth in the
appended claims, and structural and functional equivalents
thereof.
In methods that may be performed according to preferred embodiments
herein and that may have been described above and/or claimed below,
the operations have been described in selected typographical
sequences. However, the sequences have been selected and so ordered
for typographical convenience and are not intended to imply any
particular order for performing the operations.
In addition, all references cited above herein, in addition to the
background and summary of the invention sections, are hereby
incorporated by reference into the detailed description of the
preferred embodiments as disclosing alternative embodiments and
components.
* * * * *
References